WO2004071477A1 - Obtención y proceso de compuestos a partir de aceites vegetales insaturados ozonizados en composiciones farmaceuticas de uso medico y veterinario - Google Patents
Obtención y proceso de compuestos a partir de aceites vegetales insaturados ozonizados en composiciones farmaceuticas de uso medico y veterinario Download PDFInfo
- Publication number
- WO2004071477A1 WO2004071477A1 PCT/EC2003/000005 EC0300005W WO2004071477A1 WO 2004071477 A1 WO2004071477 A1 WO 2004071477A1 EC 0300005 W EC0300005 W EC 0300005W WO 2004071477 A1 WO2004071477 A1 WO 2004071477A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- ozone
- obtaining
- concentration
- total
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
Definitions
- the invention deals with a process for obtaining a stable product of natural vegetable origin, especially macadamia oil, processed in a reactor that exposes said oil to ozone in a continuous flow and subsequent feedback of terminal gases, under the action of a field electromagnetic.
- the process and production time decreases significantly under specific conditions of temperature, pressure, gas flow, pH and saturation volumes of the substance with ozone, obtained in a generator that is fed with oxygen.
- the reaction process leads to the formation of a new compound: topical ozone cream to treat infectious processes.
- the ozonized cream, subject of the present invention has the ability to penetrate and regenerate the epithelial tissue without producing skin irritations associated with previous similar treatment methods.
- the compound is stable without having a tendency to denature.
- the present invention relates to the field of application of topical compositions containing ozonized vegetable oils or their derivatives, wherein the coexistence of two or more oils has been achieved.
- the skin as an organ of greater extension is exposed to suffer injuries by natural and synthetic agents of the widest range, the same ones that can lodge in the skin, penetrate through it, destroy its structure, either by being caustic, burning, irritating or injure him through his toxins.
- agents that attack the skin are various microorganisms.
- This invention is aimed at protecting and restoring the normal structure of the skin without causing side effects.
- the process of obtaining pure macadamia oil under the action of ozone is also integrated into this field by using a reactor that allows the reactants to be exposed to high electromagnetic fields and reflows or feedbacks that shorten the time of the process very significantly.
- enzymes such as superoxide dismutase, phosphatidylhydrogenase and others, used in the field of cosmetics, skin care and acne.
- Herman in the US patent 5,190,979 speaks about the ozonide cream of linalool • for acne treatment, adding products such as propylene glycol, propyl paraben, glycerin, and for the treatment of burns adds glycerin, polyethylene glycol, among other compounds. Does not mention if side effects occur.
- the invention relates especially to the ozonization of macadamia oil, and its fatty acid derivatives, monoterpene oxides, aldehydes.
- the ozone can be added to the double bonds present in the structure of the oils, through the known mechanism of Criegee that causes the formation of ozonides.
- These ozonides are unstable in hydrophilic media, and are destroyed causing the chain to break at that point. But in hydrophobic media these ozonides are stable, and they suppose the increase of the molecular weight of the substance, since three oxygen atoms enter the molecular structure for each double bond present. This can cause the change of state of the substance.
- This reaction process is slow and requires the supply of energy to accelerate it.
- This energy can be delivered by means of temperature or other specific forms, such as the application of an electromagnetic field, which acts on the movement of each molecule that rotates as a result of this energy.
- the rotation of the molecules oriented by the applied field determines an increase of internal temperature in the system, and a higher frequency of collision between molecules.
- the energy applied in the form of electromagnetic fields favors the diffusion process of the ozone gas in the oily liquid medium and the formation reaction of the ozonides.
- Fatty acids are vital components for the human body entering in the form of triacylglycerols, they are a source of energy and play an important role in the membrane structure.
- the invention relates to the fact that pure macadamia oil is exposed to ozone in a reactor through an electromagnetic field with a frequency range between 140 and 650 MHz, (the work carried out by Rasplicka of the Yanko industries uses very low frequencies 50-60 Hz).
- a load of 2 kg of macadamia oil is used, a flow of 5 and 25 l / min is driven, of ozone at a concentration that varies between 4 and 26 g / h.
- micro bubbling through the column of the reactor must be continuous especially to reach the solid consistency that is achieved by working at a lower atmospheric pressure, corresponding to a height above 2800 meters above sea level, (differing over other researchers than work at sea level, Ozone Research Center, National Center of Scientific Research - Cuba), and with temperatures ranging between 5 and 20 degrees Celsius in the environment, additionally has implemented a feedback mechanism at the top of the column , so that the dragged elements are reincorporated to the process. All these procedures provide surprising and very positive results not expected, these new procedures were not developed in similar processes, differing from the methods of obtaining other researchers who do not reinject the gases again and do not use electromagnetic fields. (Herman et.al, patents 4,983,637-5,190,979).
- the compound obtained by this process is a cream with an ozone saturation between 60 and 95% and which can be used directly on the skin and which has been shown not to cause side effects.
- Example 1 The examples are mentioned to illustrate the present invention and should not be considered as limiting the scope thereof.
- Example 1 The examples are mentioned to illustrate the present invention and should not be considered as limiting the scope thereof.
- Example 1 The examples are mentioned to illustrate the present invention and should not be considered as limiting the scope thereof.
- the pure macadamia oil is placed in the reactor with a load of 2 kg.
- the ozone is diffused through the reactor under the action of the electromagnetic field, the gas flow is from 5 to 25 liters per minute, the ozone concentration used varies between 4 and 26 g / h.
- the ozonation is carried out for several hours until the mixture shows a pasty consistency, during all this time the final gases are fed back. After which the temperature is changed and the final product is extracted without using any additional chemical product, observed the pH the product is ready for packaging and labeling.
- Cures were applied after removing the necrotic tissue by applying an abundant layer of the product on large affected skin areas and then covering them with sterile gauze. The cures were repeated daily for 6 weeks, achieving:
- the skin is completely regenerated. No added infections were produced.
- the gauzes have less adherence to the wound. The grafts are not rejected.
- the color of the skin uniform to the surrounding area, except in patients of color.
- the new tissue does not present fragility as it happens on skin surfaces that have been under pressure and less blood flow.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003283224A AU2003283224A1 (en) | 2003-02-14 | 2003-11-06 | Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use |
US10/545,497 US7261910B2 (en) | 2003-02-14 | 2003-11-06 | Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP03-4481 | 2003-02-14 | ||
EC2003004481A ECSP034481A (es) | 2003-02-14 | 2003-02-14 | Proceso de produccion de crema estable de ozono a partir de aceites vegetales insaturados y equipo utilizado |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004071477A1 true WO2004071477A1 (es) | 2004-08-26 |
Family
ID=32864901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EC2003/000005 WO2004071477A1 (es) | 2003-02-14 | 2003-11-06 | Obtención y proceso de compuestos a partir de aceites vegetales insaturados ozonizados en composiciones farmaceuticas de uso medico y veterinario |
Country Status (4)
Country | Link |
---|---|
US (1) | US7261910B2 (es) |
AU (1) | AU2003283224A1 (es) |
EC (1) | ECSP034481A (es) |
WO (1) | WO2004071477A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050154410A1 (en) * | 2003-11-12 | 2005-07-14 | Conway William E. | Lancing device and multi-lancet cartridge |
GB0521873D0 (en) * | 2005-10-27 | 2005-12-07 | Karim Steven | Pure 03 serums |
ITMI20110354A1 (it) * | 2011-03-07 | 2012-09-08 | Neovalis S R L | Composizione a base di olio ozonizzato per uso topico |
ITMI20111045A1 (it) * | 2011-06-10 | 2012-12-11 | Uni Del Salento | Procedimento per l'ozonizzazione di un olio vegetale. |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58177908A (ja) * | 1982-04-09 | 1983-10-18 | Nippon Oil & Fats Co Ltd | 化粧料 |
US4591602A (en) * | 1982-04-16 | 1986-05-27 | James H. Brown | Ozonide esters and topical compositions containing same |
ES2162586B1 (es) * | 1999-11-25 | 2002-07-01 | Moraleda Manuel Gomez | Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5183911A (en) * | 1986-03-01 | 1993-02-02 | Dr. J. Hansler Gmbh | Process for the production of stable ozonized oils from unsaturated vegetable oils |
US4983637A (en) * | 1988-06-24 | 1991-01-08 | Stephen Herman | Method for treating viral infection of HIV |
US5190979A (en) * | 1988-06-24 | 1993-03-02 | Stephen Herman | Ozonides of terpenes and their medical uses |
ATE237298T1 (de) * | 1994-12-21 | 2003-05-15 | Cosmederm Technologies | Formulierungen und verfahren zur verminderung von hautirritationen |
FR2730636B1 (fr) * | 1995-02-16 | 1997-04-25 | Cosmart Ag | Huile vegetale naturelle enrichie en ozonides, compositions cosmetiques ou pharmaceutiques la contenant et utilisations |
JP2000351985A (ja) * | 1999-06-11 | 2000-12-19 | Nippon Ozon Kk | オゾン化植物油の生成方法及びオゾン化植物油の生成装置 |
-
2003
- 2003-02-14 EC EC2003004481A patent/ECSP034481A/es unknown
- 2003-11-06 AU AU2003283224A patent/AU2003283224A1/en not_active Abandoned
- 2003-11-06 US US10/545,497 patent/US7261910B2/en not_active Expired - Fee Related
- 2003-11-06 WO PCT/EC2003/000005 patent/WO2004071477A1/es not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58177908A (ja) * | 1982-04-09 | 1983-10-18 | Nippon Oil & Fats Co Ltd | 化粧料 |
US4591602A (en) * | 1982-04-16 | 1986-05-27 | James H. Brown | Ozonide esters and topical compositions containing same |
ES2162586B1 (es) * | 1999-11-25 | 2002-07-01 | Moraleda Manuel Gomez | Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 198347, 29 January 2004 Derwent World Patents Index; AN 1983-824550 * |
Also Published As
Publication number | Publication date |
---|---|
US20060153939A1 (en) | 2006-07-13 |
US7261910B2 (en) | 2007-08-28 |
AU2003283224A1 (en) | 2004-09-06 |
ECSP034481A (es) | 2004-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7390507B2 (en) | Compositions and methods for the treatment of radiation burns and other traumatic skin conditions | |
US4451480A (en) | Method of treating acne using ozonized materials | |
ES2628218T3 (es) | Uso de una composición espumable esencialmente libre de ingredientes farmacéuticamente activos para el tratamiento de la piel humana | |
Travagli et al. | Topical applications of ozone and ozonated oils as anti-infective agents: an insight into the patent claims | |
MXPA06001381A (es) | Vehiculo de espuma que contiene un gelificante copolimerico anfifilico. | |
MXPA06002163A (es) | Espuma farmaceutica de penetracion. | |
US20210007360A1 (en) | Solutions comprising ozonized oil | |
CY1108882T1 (el) | Φαρμακευτικο μεσο για την αγωγη ιικων δερματικων και νεοπλασιακων παθησεων | |
EP2531167A1 (en) | Hair follicle targeting compositions | |
KR20110120287A (ko) | 건선의 치료 | |
PT1502586E (pt) | Utilização de anti-sépticos no fabrico de uma preparação farmacêutica para a prevenção ou o tratamento de processos inflamatórios no interior do corpo humano | |
WO2004071477A1 (es) | Obtención y proceso de compuestos a partir de aceites vegetales insaturados ozonizados en composiciones farmaceuticas de uso medico y veterinario | |
US7521065B2 (en) | Compositions for the treatment and prevention of cancer | |
RU2166309C1 (ru) | Лечебно-профилактическая и косметическая композиция | |
US5071879A (en) | Systemic antiviral treatment | |
WO2013040721A1 (es) | Proceso y sistema para la fabricación de acietes naturales ozonizados y su aplicación el tratamiento en humanos, animales, vegetales y en acuicultura | |
CN102755255A (zh) | 一种用于止痒的纳米级脂质体外用制剂 | |
MXPA05008454A (es) | Obtencion y proceso de compuestos a partir de aceites vegetales insaturados ozonizados en composiciones farmaceuticas de uso medico y veterinario | |
IT201800009679A1 (it) | Metodo per modificare l’odore dell’olio ozonizzato | |
EP3775120A2 (en) | Solutions comprising ozonized oil | |
EP0755267A1 (en) | COMPOSITION CONTAINING OMEGA 3 AND/OR OMEGA 6 POLYUNSATURATED ACIDS HAVING FROM 12 to 22 CARBON ATOMS | |
US6936635B1 (en) | Composition for the treatment of respiratory disorders and a method for its use | |
CN105169463A (zh) | 一种阳离子婴儿医用敷料及其制备方法 | |
EP3277088B1 (en) | Nanoparticle compositions and methods for treating or preventing tissue infections and diseases | |
RU2033163C1 (ru) | Средство, стимулирующее ранозаживление и/или улучшающее обмен веществ в покровных тканях |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2005/008454 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2006153939 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10545497 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase | ||
WWP | Wipo information: published in national office |
Ref document number: 10545497 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |